Zealand Pharma raises 10.7 million Danish kroner through warrant exercises
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
June 8, 2026 11:00 AM EDTCompany announcement No. 22 / 2026
Zealand Pharma increases its share capital as a result of the exercise of employee warrants
Copenhagen, Denmark, June 8, 2026 Zealand Pharma A/S (Zealand Pharma) (NASDAQ: ZEAL) (CVR-no. 20 04 50 78), Â a biotechnology company transforming the future of metabolic health, has by decision of the Board of Directors increased its share capital by a nominal amount of DKK 53,183 divided into 53,183 new shares with a nominal value of DKK 1 each. The capital increase is a consequence of the exercise of warrants granted under one of Zealand Pharma's employee warrant programs.
... More